General Catalyst’s Steve Klasko and THL Partners’ Jessie Beegle join Christina Farr on why healthcare’s problems persist despite decades of technology — integrating AI, working around outdated systems, and aligning incentives so change actually sticks.
This week on Second Opinion, Christina Farr and Ash Zenooz interview Stephen Buck, CEO/Co-Founder of Courage Health.
This week on Second Opinion, we're sharing an episode from Peter Lee's Microsoft Research Podcast with guests Dave deBronkart and Christina Farr.
This week on Second Opinion, Christina Farr and Ash Zenooz interview Seraphina Therapeutics CEO Steph Venn-Watson, unpacking why men dominate the longevity space, the cellular secrets of aging, and C15:0’s potential to boost health.
In this episode of Second Opinion, hosts Christina Farr, Ash Zenooz, and Luba Greenwood discuss the latest trends in healthcare, including conferences, the economic impact on health tech and biotech sectors, the potential for AI to reduce administrative burdens, and the dynamics of the IPO market.
Cardiologist and Heartbeat Health CEO Dr. Jeff Wessler joins Christina Farr on why heart attacks are not random — the hard problem of behavior change in cardiology, what technology can and cannot do for prevention, and the rise of longevity-focused care.
FOLX CEO Liana Douillet Guzmán joins Christina Farr on the healthcare challenges facing the LGBTQIA+ community: systemic discrimination, the growing demand for inclusive care, and why patient-centered, community-based models work.
In this episode of Second Opinion, Christina Farr interviews Dr. Asima Ahmad MD, MPH, FACOG, Co-founder and Chief Medical Officer of Carrot, discussing her journey as a fertility specialist and entrepreneur.
This week on Second Opinion, we're featuring Christina Farr, Ash Zenooz, and Luba Greenwood's conversation with Sami Inkinen, CEO of Virta Health.
This week on Second Opinion, Christina Farr sits down with healthcare investing legend Zen Chu, who shares his framework for backing resilient entrepreneurs and insights from early investments in companies like Abridge and PillPack.
Christina Farr and Luba Greenwood sit down with Headline VC’s Georgina McMillan on how celebrity and influencer endorsements move healthcare and longevity — where they build awareness, where they spread misinformation, and what an authentic, evidence-backed partnership looks like.
